A Health Economic Analysis of the Long-Term Outcomes and Costs Associated with Using Canagliflozin Versus Sitagliptin As an Add-On to Metformin (MET) in Mexico
Abstract
Authors
A.R. Teschemaker C. Neslusan A. Puig A. Valencia P. Johansen M. Willis